1. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis. (1st November 2016) Authors: Demoly, Pascal; Okamoto, Yoshitaka; Yang, William H.; Devillier, Philippe; Bergmann, Karl-Christian Journal: Expert review of clinical immunology Issue: Volume 12:Number 11(2016) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?. Issue 5 (30th October 2021) Authors: Tanno, Luciana Kase; Castells, Mariana; Caminati, Marco; Senna, Gianenrico; Demoly, Pascal Journal: Current opinion in allergy and clinical immunology Issue: Volume 21:Issue 5(2021) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?. Issue 5 (October 2021) Authors: Tanno, Luciana Kase; Castells, Mariana; Caminati, Marco; Senna, Gianenrico; Demoly, Pascal Journal: Current opinion in allergy and clinical immunology Issue: Volume 21:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Are outcome measures in allergic diseases relevant for the WHO's International Classification of Diseases in allergology?. Issue 3 (June 2019) Authors: Tanno, Luciana Kase; Demoly, Pascal Journal: Current opinion in allergy and clinical immunology Issue: Volume 19:Issue 3(2019:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biologicals for the prevention of anaphylaxis. Issue 3 (June 2021) Authors: Tanno, Luciana Kase; Demoly, Pascal Journal: Current opinion in allergy and clinical immunology Issue: Volume 21:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. By the numbers. Issue 3 (June 2015) Authors: Demoly, Pascal; Milgrom, Henry Journal: Current opinion in allergy and clinical immunology Issue: Volume 15:Issue 3(2015:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. By the numbers: bringing new drugs for allergic/hypersensitivity diseases to the market. Issue 3 (June 2015) Authors: Demoly, Pascal; Milgrom, Henry Journal: Current opinion in allergy and clinical immunology Issue: Volume 15:Issue 3(2015:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data. (2nd September 2019) Authors: Canonica, Giorgio Walter; Devillier, Philippe; Casale, Thomas; Demoly, Pascal; Bos, Catherine; Karagiannis, Efstrathios; Passalacqua, Giovanni; Wahn, Ulrich; Mascarell, Laurent Journal: Expert review of clinical immunology Issue: Volume 15:Number 9(2019) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU). (2nd July 2016) Authors: Passalacqua, Giovanni; Sastre, Joaquín; Pfaar, Oliver; Wahn, Ulrich; Demoly, Pascal Journal: Expert review of clinical immunology Issue: Volume 12:Number 7(2016) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Economic burden of drug-induced anaphylaxis: what can we do better?. Issue 4 (August 2022) Authors: Cardoso, Barbara; Moscoso, Teresa; Morais-Almeida, Mário; Demoly, Pascal; Tanno, Luciana K. Journal: Current opinion in allergy and clinical immunology Issue: Volume 22:Issue 4(2022) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗